Viking Therapeutics, Inc. (0VQA.L) LSE

37.25

+1.7(+4.78%)

Updated at December 24 05:53PM

Currency In USD

Valuation

Market Cap4.39B
Enterprise Value4.36B
P/E Ratio-17.67
PEG Ratio0.46
Price/Sales Ratio0
Price/Book Ratio5.88
Enterprise/Revenue0
Enterprise/EBITDA-15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.29

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-150.57M
Net Income-109.96M
Diluted EPS-1.01

Balance Sheet

Total Cash714.57M
Total Cash/Share0.89
Total Debt755,000
Total Debt/Equity0
Current Ratio28.34
Book Value Per Share6.58

Price History

52-Week Change-10.07
52-Week High99.3
52-Week Low8.79
Moving Average 50 Days38.31
Moving Average 200 Days21.29

Statistics

Average Volume10,491
Shares Outstanding113.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A